Results 201 to 210 of about 61,606 (299)

Secondary severe thrombocytosis in a patient who underwent splenectomy due to hereditary spherocytosis and its treatment using hydroxyurea

, 2019
Hakan Sarbay, Sinan Akbayram
openalex   +1 more source

Hydroxyurea-induced Tongue Hypermelanosis and Transverse Melanonychia [PDF]

, 2019
Elvira Neculiseanu, Janine Harewood, Gurinder Sidhu   +2 more
openalex   +1 more source

One cell at a time: HbF distribution in sickle cell disease. [PDF]

Blood Adv
Khandros E, Steinberg MH.
europepmc   +1 more source

Integrated FHIT and IDH2 biomarker profiling predicts lethal sensitivity to DCPS inhibition in Acute Myeloid Leukemia and Myelodysplastic syndrome. [PDF]

Discov Oncol
Grassi F, Bast L, Singh M, Tobiasson M, Walfridsson J, de Milito A, Andersson M, Höglund A.   +7 more
europepmc   +1 more source

Hydroxyurea Regimen [PDF]

, 2020
openaire   +1 more source

Cutaneous squamous cell carcinomas secondary to hydroxyurea: a case report. [PDF]

An Bras Dermatol
Guerra Galvão Santos R, Martins Lobo Jardim M, Guerra Guedes L, de Lima Pereira IC.   +3 more
europepmc   +1 more source

Impact of telehealth on hydroxyurea adherence and clinical outcomes in sickle cell disease management: A systematic review and meta-analysis. [PDF]

J Manag Care Spec Pharm
Akosah A, Gokhale P, Villa Zapata L.
europepmc   +1 more source

Eliminating Interstitial Cells with Nitrogen Mustard [PDF]

, 1983
CN David, CN David, CN David, F Diehl, F Diehl, F Diehl, Goodman, L. S., and Gilman, A, RD Campbell   +7 more
core   +1 more source

Hydroxyurea therapy [PDF]

Blood, 2014
openaire   +1 more source

"Does the dose of hydroxyurea correlate with shorter hospital stay and higher fetal hemoglobin levels in patients with sickle cell disease?" [PDF]

Future Sci OA
Alzahrani MF, Albacker A, Alshabanat A, Alharbi M, Abuhaimed J, Arnous N, Alzahrani Y, Aloraier H, Alamri M, Altamimi R, Alotaibi G, Sewaralthahab S, Alshalti F, Alrumaih I, Jamal A, Algahtani F, Aleem A.   +16 more
europepmc   +1 more source